From: Update of the Preventive Antibiotics in Stroke Study (PASS): statistical analysis plan
 | Ceftriaxone + standard care (n = …) | Standard care (n = …) | P | OR 95% CI |
---|---|---|---|---|
Secondary analysis of primary outcome | Â | Â | Â | Â |
Favorable outcome - % n/N | Â | Â | Â | Â |
Secondary outcomes: | Â | Â | Â | Â |
Clinical diagnosis of infection during admission – n |  |  |  |  |
- Pneumonia | Â | Â | Â | Â |
- Urinary tract infection | Â | Â | Â | Â |
- Other | Â | Â | Â | Â |
Diagnosis of infection based on expert panel - n | Â | Â | Â | Â |
- Pneumonia | Â | Â | Â | Â |
- Urinary tract infection | Â | Â | Â | Â |
- Other | Â | Â | Â | Â |
Mortality - % n/N | Â | Â | Â | Â |
- At discharge | Â | Â | Â | Â |
- At 3 months | Â | Â | Â | Â |
Length of hospital stay - days | Â | Â | Â | NA |